Zevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphoma-Reference-Cited by-同舟云学术

Zevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphoma

Published:2015-02-17 Issue:3 Volume:34 Page:133-139
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol Oncol

Author:

Berger Martin D.¹,Branger Giacomo¹,Klaeser Bernd²,Taleghani Behrouz Mansouri³,Novak Urban¹,Banz Yara⁴,Mueller Beatrice U.⁵,Pabst Thomas¹

Affiliation:

1. Department of Medical Oncology; University Hospital; Berne Switzerland

2. Department of Nuclear Medicine; University Hospital; Berne Switzerland

3. Department of Hematology; University Hospital; Berne Switzerland

4. Institute of Pathology; University of Berne; Berne Switzerland

5. Department of Clinical Research; University of Berne; Berne Switzerland

Funder

Swiss National Science Foundation

Swiss Cancer League

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference29 articles.

1. European MCL Network. Current treatment standards and emerging strategies in mantle cell lymphoma;Dreyling;Hematology Am Soc Hematol Educ Program,2009

2. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management;Vose;Am J Hematol,2012

3. Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004;Zhou;Cancer,2008

4. How I treat mantle cell lymphoma;Ghielmini;Blood,2009

5. Alternating Courses of 3x CHOP and 3x DHAP plus rituximab followed by a high dose ARA-C containing myeloablative regimen and autologous stem cell transplantation (ASCT) is superior to 6 courses CHOP plus rituximab followed by myeloablative radiochemotherapy and ASCT in mantle cell lymphoma: results of the MCL Younger Trial of the European Mantle Cell Lymphoma Network (MCL net);Hermine;Blood,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Monoclonal Antibodies for Non-Hodgkin Lymphoma: A Literature Review;Current Cancer Therapy Reviews;2024-01

2. Combating relapsed and refractory Mantle cell lymphoma with novel therapeutic armamentarium: Recent advances and clinical prospects;Critical Reviews in Oncology/Hematology;2023-10

3. Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma;Cancers;2023-03-31

4. BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom’s Macroglobulinemia;Journal of Clinical Medicine;2023-03-19

5. Worked to the bone: antibody-based conditioning as the future of transplant biology;Journal of Hematology & Oncology;2022-05-19